Clinical AI Human Factors Assessment

Core Elements of the Assessment

Four components define a complete clinical AI human factors assessment. Together they establish what can go wrong at the point of clinician interaction, how output design should be refined, how final task performance is validated, and when the work must be repeated.

• Use-Related Risk Analysis Mapping critical tasks where clinician misinterpretation of AI output could cause harm.
• Formative Testing Early, iterative evaluation of clinician interpretation as output design evolves.
• Summative Testing Pre-deployment validation of critical task performance under realistic conditions.
• Lifecycle Reassessment Retesting triggered by model, interface, or workflow changes.

What Distinguishes This From General Usability Testing

General software usability testing asks whether users can operate an interface efficiently. A clinical AI human factors assessment asks a narrower and higher-stakes question: whether a clinician correctly interprets an AI-generated output, forms an appropriate level of trust in it, and takes a clinically appropriate action as a result. This distinction matters because AI outputs in clinical settings, such as diagnostic suggestions, risk scores, or decision support alerts, carry direct patient safety consequences if misread, over-trusted, or ignored.

There is no dedicated, standardized framework built specifically for clinical AI human factors assessment. In practice, the method extends established medical device usability engineering standards, primarily FDA human factors guidance and IEC 62366-1, to AI/ML-enabled outputs. This means the assessment inherits a rigorous, risk-based structure rather than relying on generic usability heuristics or one-off clinician feedback sessions.

The Core Method: Use-Related Risk Analysis and Two-Phase Testing

The analytic backbone of the assessment is use-related risk analysis, as defined under IEC 62366-1. This step requires mapping out use scenarios and distinguishing critical tasks, where a use error could cause harm, from routine tasks that carry lower risk. For clinical AI, critical tasks typically include accepting, rejecting, or escalating an AI-generated recommendation, and correctly interpreting confidence indicators or alert thresholds attached to that recommendation.

FDA human factors and usability engineering guidance structures the testing itself into two phases. Formative testing is iterative and occurs early, refining how outputs are presented based on clinician feedback under realistic conditions. Summative testing validates the final design before deployment, confirming that representative clinicians correctly perform critical tasks. Good Machine Learning Practice guiding principles, jointly issued by FDA, Health Canada, and the UK MHRA, frame human factors as a continuous lifecycle activity rather than a single pre-deployment check, which has direct implications for how often this testing should recur.

Regulatory and Standards Context

Several recent developments shape expectations for this work. HTI-1, finalized by ONC/ASTP, requires certified health IT developers to provide transparency information, referred to as source attributes, for predictive decision support interventions. This gives health systems a baseline of information needed to evaluate AI outputs during human factors testing rather than relying solely on vendor assurances. NIST AI Risk Management Framework identifies human-AI configuration as a distinct trustworthiness function, explicitly calling for evaluation of how output presentation affects clinician reliance, override behavior, and disuse.

GMLP guiding principles reinforce that human factors evaluation should be addressed across the full AI/ML lifecycle, not treated as a single gate before go-live. Governance teams should verify the current status of any newer FDA guidance addressing AI-enabled device lifecycle management before citing it in internal policy, since confirmed publication details were not available at the time of this guide.

Connecting Assessment Findings to AI Governance

A completed human factors assessment is only useful to an organization if its findings feed into broader governance artifacts: the AI risk register, model documentation, and deployment sign-off records. This is what makes the assessment auditable rather than a one-time internal exercise. Post-deployment, the same critical tasks identified during risk analysis, such as override, dismissal, and escalation actions, should continue to be observed in production to detect drift in how clinicians interact with the system over time.

Runtime governance capabilities, including audit logging and monitoring of agent and tool interactions, can support this ongoing observation by recording how AI-generated recommendations are acted on in practice. This does not replace the formal human factors assessment but extends its findings into an operational record that governance teams can review against the original risk analysis and mitigation decisions.